Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Argus Health
Accenture
McKinsey
Express Scripts
AstraZeneca
Novartis
Dow
Boehringer Ingelheim

Generated: January 19, 2018

DrugPatentWatch Database Preview

Tazarotene - Generic Drug Details

« Back to Dashboard

What are the generic sources for tazarotene and what is the scope of tazarotene patent protection?

Tazarotene
is the generic ingredient in four branded drugs marketed by Mayne Pharma, Allergan, and Taro, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Tazarotene has nineteen patent family members in thirteen countries.

There are eight drug master file entries for tazarotene. Six suppliers are listed for this compound.
Pharmacology for tazarotene
Ingredient-typeRetinoids
Drug ClassRetinoid

US Patents and Regulatory Information for tazarotene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-001 Sep 29, 2000 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allergan AVAGE tazarotene CREAM;TOPICAL 021184-003 Sep 30, 2002 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-002 Sep 29, 2000 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mayne Pharma FABIOR tazarotene AEROSOL, FOAM;TOPICAL 202428-001 May 11, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Taro TAZAROTENE tazarotene CREAM;TOPICAL 208258-001 Apr 3, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for tazarotene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 ➤ Subscribe ➤ Subscribe
Allergan AVAGE tazarotene CREAM;TOPICAL 021184-003 Sep 30, 2002 ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-001 Sep 29, 2000 ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-002 Sep 29, 2000 ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 ➤ Subscribe ➤ Subscribe
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for tazarotene

Supplementary Protection Certificates for tazarotene

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/002 United Kingdom ➤ Subscribe PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730
C0008 Belgium ➤ Subscribe PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203
/1998 Austria ➤ Subscribe PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Moodys
Queensland Health
McKesson
McKinsey
Julphar
Fuji
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot